Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Linking lipids, Alzheimer's and LXRs?

Nilay V Patel1, Barry Marc Forman

  • 1Gonda Diabetes Center, City of Hope National Medical Center, Duarte, CA 91010, USA.

Nuclear Receptor Signaling
|April 11, 2006
PubMed
Summary

This review explores how cholesterol metabolism might influence the development of Alzheimer's disease. The authors examine the role of beta-amyloid accumulation and how altered cholesterol levels could affect this process. They focus on the potential role of liver X receptors (LXRs), which are involved in cholesterol regulation. The findings suggest that cholesterol signaling may modulate amyloid pathology, but the exact mechanisms remain unclear. The review does not propose definitive therapeutic strategies but highlights the need for further research into lipid metabolism and Alzheimer's disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Eosinophilic Myocarditis Demonstrated Using Cardiac Magnetic Resonance Imaging in a Patient with Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Disease).

Cureus·2018
Same author

Causes and Predictors of Readmission in Patients With Atrial Fibrillation Undergoing Catheter Ablation: A National Population-Based Cohort Study.

Journal of the American Heart Association·2018
Same author

The National Inpatient Sample Is Not an Appropriate Database to Assess the Incidence of Spontaneous Coronary Artery Dissection.

JACC. Cardiovascular interventions·2018
Same author

Short-term outcomes of atrial flutter ablation.

Journal of cardiovascular electrophysiology·2017
Same author

Design, synthesis and identification of a new class of triarylmethyl amine compounds as inhibitors of apolipoprotein E production.

Bioorganic & medicinal chemistry letters·2012
Same author

Glycogen synthase kinase 3 (GSK3) inhibitor, SB-216763, promotes pluripotency in mouse embryonic stem cells.

PloS one·2012

Area of Science:

  • Neurodegenerative disease mechanisms in molecular biology
  • Lipid metabolism research in neurological disorders
  • Receptor signaling pathways in Alzheimer's disease

Background:

Understanding how cholesterol metabolism influences Alzheimer's disease remains an open question in neuroscience. Prior research has shown that beta-amyloid accumulation is a hallmark of AD pathology. However, the mechanisms linking cholesterol homeostasis to amyloid production are not fully resolved. Established knowledge suggests that cholesterol levels affect lipid raft composition, which in turn may influence amyloid precursor protein processing. No prior work had resolved how oxysterol receptors might modulate this process. This gap motivated further investigation into the role of cholesterol-related signaling in AD. The field has yet to determine whether cholesterol regulation could serve as a therapeutic target. This uncertainty drives current efforts to explore the molecular connections between lipid metabolism and amyloid pathology. The need for clarity on these interactions remains central to advancing Alzheimer's research.

Purpose Of The Study:

Keywords:
Alzheimer's disease mechanismsCholesterol metabolism in neurodegenerationLiver X receptor signalingAmyloid pathology

Frequently Asked Questions

The authors suggest that altered cholesterol homeostasis may modulate beta-amyloid production and accumulation, potentially influencing Alzheimer's disease progression.

Recent data suggest that liver X receptors may modulate cholesterol and amyloid interactions, possibly influencing amyloid pathology in Alzheimer's disease.

The review indicates that cholesterol levels may affect lipid raft composition, which could influence amyloid precursor protein cleavage and amyloid accumulation.

Oxysterol receptors, such as liver X receptors, are proposed to modulate cholesterol and amyloid interactions, suggesting a potential therapeutic role in Alzheimer's disease.

Related Experiment Videos

The purpose of this review is to examine the relationship between cholesterol metabolism and Alzheimer's disease progression. The study aims to clarify how altered cholesterol homeostasis may influence beta-amyloid production. Researchers focus on identifying molecular pathways that link lipid regulation to amyloid accumulation. The motivation for this work stems from the need to better understand the role of cholesterol in AD pathology. By analyzing recent findings, the authors hope to shed light on potential therapeutic strategies. The study also seeks to evaluate the relevance of oxysterol receptors in this context. This work addresses a key question in neurodegenerative disease research. The findings may help guide future investigations into lipid-based interventions for AD.

Main Methods:

The authors use a literature review approach to synthesize findings on cholesterol and Alzheimer's disease. They analyze molecular mechanisms connecting lipid metabolism to amyloid production. The review includes studies on oxysterol receptors and their potential role in AD. The approach involves evaluating published data on cholesterol homeostasis and amyloid pathology. The researchers assess how cholesterol regulation influences amyloid precursor protein processing. They also consider recent evidence on liver X receptor (LXR) signaling in the brain. The synthesis draws on findings from both preclinical and clinical studies. The review integrates data from multiple disciplines to present a comprehensive overview.

Main Results:

The strongest finding is that cholesterol homeostasis modulates beta-amyloid production and accumulation. Recent data suggest that oxysterol receptors may influence amyloid pathology. Liver X receptors (LXR) appear to play a role in regulating cholesterol and amyloid interactions. The review highlights how altered lipid metabolism affects amyloid precursor protein processing. Evidence indicates that LXR activation may reduce amyloid accumulation in preclinical models. The findings suggest that cholesterol signaling pathways are relevant to AD progression. The data also show that lipid rafts may serve as sites for amyloid precursor protein cleavage. These results provide a foundation for further investigation into lipid-based therapies.

Conclusions:

The authors synthesize evidence suggesting that cholesterol metabolism influences Alzheimer's disease pathology. They propose that altered lipid homeostasis may modulate beta-amyloid production. The review highlights the potential role of liver X receptors in this process. The findings suggest that cholesterol signaling could be a target for therapeutic intervention. The authors emphasize the need for further research to clarify these mechanisms. They note that current data support a connection between lipid metabolism and amyloid accumulation. The conclusions reflect the importance of understanding cholesterol-related pathways in AD. The review does not assign essentiality but suggests that these findings may guide future studies.

The review highlights preclinical data showing that LXR activation may reduce amyloid accumulation, suggesting a connection between lipid metabolism and amyloid pathology.

The authors suggest that these findings may guide future investigations into lipid-based therapies for Alzheimer's disease, though no definitive therapeutic targets are proposed.